CytomX Therapeutics

CTMXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$753.252 M

$3.46 +2.67%

Close of 7 Aug 2026

Revenue

$76.2M

#2611 by revenue

Earnings

-$17.4M

Loss-making

Shares outstanding

217,899,284

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#179Pharming GroupPHAR$773.3M
#180CryoportCYRX$762.1M
#181CytomX TherapeuticsCTMX$753.3M
#182Rigel PharmaceuticalsRIGL$750.4M
#183BridgeBio Oncology TherapeuticsBBOT$747.4M

Where these numbers come from

Share counts and financials for CytomX Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.